A Headlands Research Site
About Headlands Research
Capabilities
Site Network
Team
Facebook
Twitter
LinkedIn
Donate Now
About Us
Medical Director
Our Team
Our Facility
Careers
Patients
Memory Clinic
Movement Disorders Clinic
Free Memory Assessment
Frequently Asked Questions
Clinical Trials
Physicians
Sponsors
Clinical Trials
Current Studies
Free Memory Assessment
Frequently Asked Questions
Diversity & Inclusion
Media
Contact
Media
Toronto Memory Program in the Media
Hope and anxiety surround new Alzheimer’s drug lecanemab
Experimental drug appears to slow progression of Alzheimer’s disease in clinical trial but raises safety concerns
A New Drug Could Slow Alzheimer’s Disease, Data Show
A potential breakthrough in Alzheimer’s research needs Canadians’ help to move forward
An experimental Alzheimer’s drug could be approved next year. But it comes with risks
Ontario not ready for new Alzheimer’s treatment
Assessing Lecanemab’s Effect in Early Alzheimer Disease: Sharon Cohen, MD, FRCPC
Dr. Sharon Cohen on Medcan’s podcast series called Eat, Move, Think!
Dr. Sharon Cohen on CanadaTalks with Matt Gurney
CTV News Channel with Dr. Sharon Cohen on FDA approval of Aducanumab
Cassava sciences – Sumifilam
Toronto Memory Program and Fundraiser Steve McNeil Featured on CTV News Toronto
Toronto Memory Program’s Dr Ian Cohen and Skate-a-Thon Fundraiser Steve McNeil Featured on CTV News
Dr Sharon Cohen Featured in CNBC Report on Biogen’s Aducanumab during PBS Business News Hour
Toronto Memory Program’s Retinal Scan for Alzheimer’s Featured on CTV News
